<--- Back to Details
First PageDocument Content
Clinical research / Center for Biologics Evaluation and Research / Food and Drug Administration / Influenza / Mahendra Rao / Maryland / Centers for Disease Control and Prevention / United States Public Health Service / Medicine / Health
Clinical research
Center for Biologics Evaluation and Research
Food and Drug Administration
Influenza
Mahendra Rao
Maryland
Centers for Disease Control and Prevention
United States Public Health Service
Medicine
Health

1 U.S. FOOD AND DRUG ADMINISTRATION + + + + + CENTER FOR BIOLOGICS EVALUATION AND RESEARCH + + + + +

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 785,65 KB

Share Document on Facebook

Similar Documents

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

DocID: 1ogsZ - View Document

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

DocID: 1gkCa - View Document

   Global	
  Healthy	
  Living	
  Foundation	
   515	
  North	
  Midland	
  Avenue	
   Upper	
  Nyack,	
  New	
  York	
  10960	
  USA	
   +1	
  845	
  348	
  0400	
  

  Global  Healthy  Living  Foundation   515  North  Midland  Avenue   Upper  Nyack,  New  York  10960  USA   +1  845  348  0400  

DocID: 1g1KY - View Document

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

DocID: 1fuJJ - View Document

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DocID: 1aZ0Q - View Document